Press Releases

  • 09/13/11Analyses Find Type 2 Diabetes Patients Treated with BYDUREON Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD2011
  • 09/08/11Alkermes Announces Shareholder Vote in Favor of Merger with Elan Drug Technologies
  • 09/07/11Alkermes' Corporate Presentation to be Webcast at Two Upcoming Conferences
  • 08/31/11Alkermes' Corporate Presentation to Be Webcast at Baird's 2011 Health Care Conference
  • 08/10/11BYDUREON FDA Action Date Set For January 28, 2012
  • 08/01/11Alkermes Reports First Quarter Fiscal 2012 Financial Results
  • 07/28/11BYDUREON Reply Submitted to FDA

Other Resources

Email Alerts

Stay in Touch with Alkermes